BioSpace News Archive

Deep Blue Medical Advances announced today it has received the Luis Villalobos Award – Life Sciences from the Angel Capital Association (ACA), a professional association of more than 15,000 accredited angel investors and 250 angel groups, accredited platforms and family offices across North America.

RenovoRx, Inc. (“RenovoRx” or the “Company”) (Nasdaq: RNXT), a clinical-stage biopharmaceutical company developing novel precision oncology therapies based on a local drug-delivery platform, today announced a publication of pre-clinical studies supporting the efficacy and drug delivery mechanism of RenovoRx’s Trans-Arterial Micro-Perfusion (“TAMP”) therapy platform.

Daiichi Sankyo (TSE: 4568) will present new clinical research across its oncology portfolio with more than 45 abstracts in multiple cancers at the 2024 American Society of Clinical Oncology Scientific Program (#ASCO24).

Inspirna, Inc. announced today the appointment of Karim Benhadji, M.D., as Chief Medical Officer, effective May 1, 2024.

Pristine Surgical today announced the addition of Christopher Cleary to its Board of Directors.

Theranica, a neuromodulation therapeutics company, today announced DC Medicaid’s coverage of the Nerivio® REN wearable, the first and only FDA-cleared, non-drug, non-disruptive treatment for both acute attacks and prevention of migraine with or without aura in adolescents and adults ages 12 and older.

Biodexa Pharmaceuticals PLC is pleased to announce that results of a Phase 2 clinical trial of eRapa in Familial Adenomatous Polyposis (“FAP”) (NCT04230499) are scheduled for presentation at the prestigious 2024 Digestive Disease Week annual meeting in Washington D.C.. Carol Burke, MD, the Principal Investigator, will present the six month data in a podium presentation at the meeting.

Alpha Tau Medical Ltd. today announced that CFO Raphi Levy will present a corporate overview and update at the Jefferies Global Healthcare Conference on June 5 th , 2024.

Engitix Ltd announces the appointment of Matthew Edwards, Ph.D., as Senior Vice President of Discovery Sciences, and Emma Huang, Ph.D., as Vice President of Data Sciences.

HighField Biopharmaceuticals announced that its abstract of preclinical data evaluating an mRNA-based GLP-1R agonist in diabetic monkeys has been accepted for a poster presentation at the American Diabetes Association 84th Scientific Sessions June 21-24, 2024, in Orlando, FL.